CJC/Ipamorelin Blend
Also known as: CJC-1295/Ipamorelin, GH Combo
Combined GHRH analog (CJC-1295 no DAC) + ghrelin mimetic (Ipamorelin); synergistic GH release through dual-pathway stimulation.
- Typical dose
- 200 mcg – 500 mcg
- Frequency
- once daily
- Route
- Subcutaneous
- Half-life
- 30 minutes
- Routes
- Subcutaneous
- Status
- Research chemical (compounded blend)
Benefits
- Synergistic GH pulse
- Better than either alone
- Fat loss + muscle gain
- Improved sleep quality
Dosing
A common research range for CJC/Ipamorelin Blend is 200 mcg to 500 mcg once daily. Typical blend: 100mcg CJC + 200mcg Ipa; inject before bed. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.
Reconstitution
A typical reconstitution for CJC/Ipamorelin Blend is 5 mg of peptide in 2 mL of bacteriostatic water, giving roughly 2.5 mg per mL. Vial's built-in calculator works out the exact syringe draw for any vial size and dose.
Half-life
CJC/Ipamorelin Blend has an approximate half-life of 30 minutes. Vial plots the real concentration curve from your logged doses so you can see peak windows and when levels taper.
Storage
2-8°C post-reconstitution; use within 30 days.
Reported side effects
- Head rush
- Flushing
- Hunger increase
- Tingling
Contraindications
- Active cancer
- Pituitary disorders
Track CJC/Ipamorelin Blend with Vial
Vial logs every CJC/Ipamorelin Blend dose, plots its half-life curve, calculates reconstitution math, and keeps your whole protocol on schedule — on-device and private. Download Vial on the App Store →
This page is for educational and harm-reduction purposes only. CJC/Ipamorelin Blend is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.